These studies revealed that elevated serum IGF-1 in the Hi-Myc/HIT mice was associated with prostate enlargement, invasive prostate cancer, and more-aggressive prostate adenocarcinoma, which did not occur in Hi-Myc mice with normal levels of serum IGF-131. The gene discussed is MYC; the disease is prostate adenocarcinoma.